Litman Gregory Wealth Management LLC Novartis Ag Transaction History

Litman Gregory Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 27, 2021	SELL	$85.24 - $94.15 $39,977 - $44,156	-469 Closed	0 $0
Q1 2020 Apr 28, 2020	SELL	$70.67 - $99.01 $4,310 - $6,039	-61 Reduced 11.51%	469 $39,000
Q4 2019 Jan 30, 2020	BUY	$84.35 - $95.37 $10,965 - $12,398	130 Added 32.5%	530 $50,000
Q2 2018 Aug 09, 2018	SELL	$64.91 - $73.36 $35,700 - $40,348	-550 Reduced 57.89%	400 $30,000
Q1 2018 May 07, 2018	BUY	$70.39 - $84.15 $66,870 - $79,942	950 New	950 $77,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Litman Gregory Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Litman Gregory Wealth Management LLC with notifications on news.